SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2005 / Cilt: 11 - Sayı: 5

A case of idiopathic hypoparathyroidism with cognitive impairment

Kognitif bozuklukla başvuran poliglandüler otoimmun Tip I sendromlu bir olgu

Aybige PİLANCI
Ayşin HARMANDA
Orhan KÜÇÜKŞAHİN
Umut ÇAĞLAR
Pages
478–481
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report we discussed a case of polyglandular autoimmune syndrome type 1 with cognitive impairment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:IHP is a disease with unknown etiology, caused by insufficient secretion of parathyroid hormone (PTH).
📊
Key Findings & Data:IHP usually effects ectodermal tissues.
💡
Conclusion & Impact:In this report we discussed a case of polyglandular autoimmune syndrome type 1 with cognitive impairment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Paratiroid hormonu · Kalsinoz · Poliendokrinopatiler

Abstract

IHP is a disease with unknown etiology, caused by insufficient secretion of parathyroid hormone (PTH). IHP usually effects ectodermal tissues. Skin and central nerveous system are generally effected from IHP and bilateral calcifications in the basal ganglia may be seen. IHP might appear together with polyglandular autoimmun syndromes. The diagnosis of polyglandular autoimmun syndrome may take quıte a long time because ıt has a lot of nonspecific symptoms. In this report we discussed a case of polyglandular autoimmune syndrome type 1 with cognitive impairment.

Özet

İdiopatik hipoparatiroidi (İHP) parathormonun (PTH) paratiroid bezinden yetersiz salınımı ile ortaya çıkan ve etyolojisi bilinmeyen bir hastalıktır. İHP'de genellikle ektoderm kökenli dokular etkilenmektedir. Cilt, santral sinir sistemi tutulumu ve özellikle bazal ganglia kalsifikasyonlarına sık rastlanılmaktadır. İHP poliglandüler otoimmun sendromlarla birlikte görülebilmektedir. Klinik bulgulardaki çeşitlilik ve semptomların nonspesifik olması nedeni ile poliglandüler otoimmun sendrom tanısı genellikle yıllar sonra konulabilmektedir. Bu yazımızda kognitif bozuklukla başvuran poliglandüler otoimmun tip 1 sendromlu bir olguya yer verdik.

🔖

Cite This Article

PİLANCI, A., HARMANDA, A., KÜÇÜKŞAHİN, O., ÇAĞLAR, U. (2005). A case of idiopathic hypoparathyroidism with cognitive impairment. Medical Network Klinik Bilimler ve Doktor, Cilt: 11 - Sayı: 5, 478–481. https://ajindex.com/articles/278386

References (1)

  1. Rose NR. Is idiopathic hypoparathyroidism an autoimmune îease? J Clin Invest 1996; 97:899-900. 2-Stelmasiak Z, Tarach JS, Tarach BM et al. İdiopathic poparathyroidism with intracranial calcifacations and dominant in manifestations. Med Sci Monit 2000; 6:145-50. 3-Betterle C, Greggio NA, Volpato M. Autoimmune •lyglandular syndrome type 1. J Clin Endocrinol Metab 1998; i:1049-55. 4-Meriluoto T, Halonen M, Pelto-Huikko M, Kangas H, >rhonen J, Kolmer M, Ulmanen I, Eskelin P. The autoimmune gulator: a key toward understanding the molecular pathogenesis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Keio J Med 2001; 50:225-39. 5.Finnish-German APECED Consortium.An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997;17:399-403. 6.Betterle C, Volpato M, Rees Smith B, et al. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab 1997; 82:932-8. 7.Betterle C, Volpato M, Rees Smith B, et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997; 82:939-42. 8.Chevalley T, Rizzoli R. Bone and hormones. Effects of parathyroid hormone on the bone. Presse Med 1999; 28:547-53. 9.Chow KS, Lu DN: Primary hypoparathyroidism with bazal ganglia calcification:report of case.Chung Hua Min Kuo Hsiao Erh Ko I Shueh Hui Tsa Chih 1989; 30:129-33. 10.Friedman JH, Chiucchini I, Tucci JR:ldiopathic hypoparathyroidism with extensive brain calcification and persistent neurologic disfunction.Neurology 1987; 37:307-9. 11.Koch CA. Rapid increase in bone mineral density in a child with osteoporosis and autoimmune hypoparathyroidism treated with PTH1-34. Exp Clin Endocrinol Diabetes 2001; 109:350-4. 12.Kowdley KV, Coull BM, Orwoll ES. Cognitive impairment and intracranial calcification in chronic hypoparathyroidism. Am J Med Sci 199; 31:273-7. 13.Winer KK, Yanovski JA, Sarani B, Cutler GB. A randomized,cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 1998; 83:3480-6.